Continuous EPO receptor activator therapy of anemia in children under peritoneal dialysis
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
item.page.accessRights
item.page.other
item.page.references
Abstract
The short half-life of erythropoietin (rHuEPO) leads to repeated fluctuations in hemoglobin levels and the need for frequent administration. Continuous erythropoietin receptor activator (CERA) therapy...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Pediatric Nephrology, 2011, vol. 26, n° 8, p. 1303-1310
Keywords
Erythropoietin , EPO , CERA , Anemia , Children , Peritoneal dialysis
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026